DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines

被引:49
|
作者
Kawamoto, Ken [2 ]
Hirata, Hiroshi [2 ]
Kikuno, Nobuyuki [2 ]
Tanaka, Yuichiro [2 ]
Nakagawa, Masayuki [3 ]
Dahiya, Rajvir [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, Urol Res Ctr 112F, Dept Urol, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94121 USA
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan
关键词
sFRP2; gene; Wnt antagonist; DNA methylation; histone modification; renal cell carcinoma;
D O I
10.1002/ijc.23514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Secreted frizzled-related protein 2 (sFRP2) is a negative modulator of the Wingless-type (Wnt) signaling pathway, and shown to be inactivated in renal cell carcinoma (RCC). However, the molecular mechanism of silencing of sFRP2 is not fully understood. Our study was designed to elucidate the silencing mechanism of sFRP2 in RCC. Expression of sFRP2 was examined in 20 pairs of primary cancers by immunohistochemistry. Kidney cell lines (HK-2, Caki-1, Caki-2, A-498 and ACHN) were analyzed for sFRP2 expression using real-time RT-PCR and Western blotting. The methylation status at 46 CpG sites of the 2 CpG islands in the sFRP2 promoter was characterized by bisulfite DNA sequencing. Histone modifications were assessed by chromatin immunoprecipitation (ChIP) assay using antibodies against AcH3, AcH4, H3K4 and H3K9. sFRP2 was frequently repressed in primary cancers and in RCC cells. The majority of sFRP2 negative cells had a methylated promoter. Meanwhile, sFRP2 expression was repressed by a hypomethylated promoter in Caki-1 cells, and these cells had a repressive histone modification at the promoter. In Caki-1 cells, sFRP2 was reactivated by trichostatin A (TSA). Repressive histone modifications were also observed in RCC cells with hypermethylated promoters, but sFRP2 was reactivated only by 5-aza-2'-deoxycytidine (DAC) and not by TSA. However, the activation of the silenced sFRP2 gene could be achieved in all cells using a combination of DAC and TSA. This is the first report indicating that aberrant DNA methylation and histone modifications work together to silence the sFRP2 gene in RCC cells. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:535 / 542
页数:8
相关论文
共 50 条
  • [41] The landscape of histone modifications across 1% of the human genome in five human cell lines
    Koch, Christoph M.
    Andrews, Robert M.
    Flicek, Paul
    Dillon, Shane C.
    Karaoz, Ulas
    Clelland, Gayle K.
    Wilcox, Sarah
    Beare, David M.
    Fowler, Joanna C.
    Couttet, Phillippe
    James, Keith D.
    Lefebvre, Gregory C.
    Bruce, Alexander W.
    Dovey, Oliver M.
    Ellis, Peter D.
    Dhami, Pawandeep
    Langford, Cordelia F.
    Weng, Zhiping
    Birney, Ewan
    Carter, Nigel P.
    Vetrie, David
    Dunham, Ian
    GENOME RESEARCH, 2007, 17 (06) : 691 - 707
  • [42] Histone Deacetylase Inhibitors and Epigenetic Modifications as a Novel Strategy in Renal Cell Carcinoma
    Ramakrishnan, Swathi
    Pili, Roberto
    CANCER JOURNAL, 2013, 19 (04): : 333 - 340
  • [43] Analysis of histone modifications at human ribosomal DNA in liver cancer cell
    Feng Yu
    Xingyong Shen
    Li Fan
    Zhaocai Yu
    Scientific Reports, 5
  • [44] Analysis of histone modifications at human ribosomal DNA in liver cancer cell
    Yu, Feng
    Shen, Xingyong
    Fan, Li
    Yu, Zhaocai
    SCIENTIFIC REPORTS, 2015, 5
  • [45] Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma
    Hirata, Hiroshi
    Hinoda, Yuji
    Nakajima, Koichi
    Kawamoto, Ken
    Kikuno, Nobuyuki
    Ueno, Koji
    Yamamura, Soichiro
    Zaman, Mohd S.
    Khatri, Gaurav
    Chen, Yi
    Saini, Sharanjot
    Majid, Shahana
    Deng, Guoren
    Ishii, Nobuhisa
    Dahiya, Rajvir
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (08) : 1793 - 1803
  • [46] DNA Hypermethylation and Partial Gene Silencing of Human Thymine-DNA Glycosylase in Multiple Myeloma Cell Lines
    Peng, Benjamin
    Hurt, Elaine M.
    Hodge, David R.
    Thomas, Suneetha B.
    Farrar, William L.
    EPIGENETICS, 2006, 1 (03) : 138 - 145
  • [47] Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation
    Li, Xiaoqing
    Liu, Jun
    Zhou, Rui
    Huang, Shi
    Huang, Shiang
    Chen, Xian-Ming
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (01) : 69 - 79
  • [48] A systematic profile of DNA methylation in human cancer cell lines
    Paz, MF
    Fraga, MF
    Avila, S
    Guo, MZ
    Pollan, M
    Herman, JG
    Esteller, M
    CANCER RESEARCH, 2003, 63 (05) : 1114 - 1121
  • [49] Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines
    Erandi Ayala-Ortega
    Rodrigo Arzate-Mejía
    Rosario Pérez-Molina
    Edgar González-Buendía
    Karin Meier
    Georgina Guerrero
    Félix Recillas-Targa
    BMC Cancer, 16
  • [50] Analysis of the methylation status of HPV DNA in human cell lines
    Rocio S Méndez
    Cristian P Miguez
    Miriam C Guido
    Alejandro García-Carrancá
    BMC Cancer, 7 (Suppl 1)